![Loading Events](https://lifescievents.com/wp-content/plugins/the-events-calendar/src/resources/images/tribe-loading.gif)
Orchestra Biomed In-Person R&D Day on AVIM Therapy Program in Hypertensive Pacemaker Patients
![Banners (54) Banners (54)](https://lifescievents.com/wp-content/uploads/2024/04/Banners-54.png)
DATE: | June 11, 2024 |
---|---|
TIME: | 10:00 AM EDT |
LOCATION: |
Lotte New York Palace Hotel, 455 Madison Ave
New York, 10022 United States |
About The Event
The event will feature presentations by company management and key opinion leaders related to the Company’s lead program, atrioventricular interval modulation (AVIM) therapy, including:
- David Kandzari, M.D., FACC, FSCAI, Chief, Piedmont Heart Institute and Cardiovascular Services, Chief Scientific Officer, Piedmont Healthcare, Director, Interventional Cardiology, Piedmont Heart Institute, and Co-principal investigator for the BACKBEAT global pivotal study
- Vivek Reddy, M.D., Director of Cardiac Arrhythmia Services at Mount Sinai Hospital, Director of Electrophysiology at Mount Sinai Health System, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, and Clinical Steering Committee Advisor for the BACKBEAT global pivotal study
The R&D day program will focus on a review of:
- Current treatment landscape and significant unmet need for pacemaker-indicated patients with uncontrolled hypertension;
- AVIM therapy mechanism of action and supporting clinical and non-clinical mechanistic data;
- Existing body of clinical evidence from the MODERATO I and II studies;
- Design of the BACKBEAT global pivotal study.
A live question and answer session will follow formal presentations.